Our team will give you a clear time estimate when you book
Clinical trials published in the New England Journal of Medicine demonstrated that participants using semaglutide at a 2.4 mg weekly dose lost an average of 14.9 percent of their body weight over 68 weeks, compared to just 2.4 percent with placebo
Personalized Prescription: We provide compounded semaglutide and tirzepatide to assist with weight loss, enhance your well-being, and reduce the risk of serious health conditions
We offer real-time audio-visual telehealth visits for patients anywhere in Washington state
They had never actually met with a provider, and they received zero counseling on side effects, lifestyle, or nutrition
CJC-1295 without DAC has a short half-life of around 30 minutes, making it better suited for research into pulsatile GH release